 |
A newsletter for those involved in clinical trials. Published 20 times a
year by Canary LtdCenter for Drug Evaluation and Research
The following articles on this topic have been published in
CRAdvisor (CRA) – the year, issue number
and starting page number for each are listed below:
Back to index |
|
2007 |
|
|
CRA 2007; 187:6 |
CDER warning letters highlight investigator failings. |
|
CRA 2007; 192:7 |
CDER issues new warnings to investigators. |
|
|
|
|
2005 |
|
|
CRA 2005; 148:6
|
New procedures for review of cancer therapies. |
|
|
|
|
2004 |
|
|
CRA 2004; 138:7
|
CDER helps consumers to recognise dangers of medicines. |
|
|
|
|
2003 |
|
|
CRA 2003; 103:6 |
FDA consolidation of products between CBER and CDER continues. |
|
CRA 2003; 112:8 |
CDER draft guidance. |
|
CRA 2003; 120:7 |
Consumer information sheets on the Internet. |
|
CRA 2003; 120:7 |
List of CDER guidance. |
|
|
|
|
2002 |
|
|
CRA 2002; 88:6
|
Fast track designation. |
|
CRA 2002; 98:6 |
CDER to oversee biologicals. |
|
CRA 2002; 99:6 |
Need to know who to contact? |
|
|
|
|
2001 |
|
|
CRA 2001; 75:6 |
FDA guidance agenda. |
|
|
|
|
2000 |
|
|
CRA 2000; 41:6 |
History of CDER. |